Evidence map›Paper›PMID 29709005›Full record

ArticlePloS one2018

Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system.

Radoslaw Kaczmarek, Katarzyna Szymczak-Kulus, Anna Bereźnicka, Krzysztof Mikołajczyk, Maria Duk, Edyta Majorczyk, Anna Krop-Watorek, Elżbieta Klausa, Joanna Skowrońska, Bogumiła Michalewska and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Radoslaw KaczmarekLaboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.ORCID 0000-0001-8084-1958
Katarzyna Szymczak-KulusLaboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Anna BereźnickaLaboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Krzysztof MikołajczykLaboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Maria DukLaboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Edyta MajorczykFaculty of Physical Education and Physiotherapy, Opole University of Technology, Opole, Poland.
Anna Krop-WatorekDepartment of Biotechnology and Molecular Biology, University of Opole, Opole, Poland.
Elżbieta KlausaRegional Centre of Transfusion Medicine and Blood Bank, Wroclaw, Poland.
Joanna SkowrońskaRegional Centre of Transfusion Medicine and Blood Bank, Katowice, Poland.
Bogumiła MichalewskaDepartment of Immunohaematology and Immunology of Transfusion Medicine, Institute of Haematology and Blood Transfusion, Warsaw, Poland.
Ewa BrojerDepartment of Immunohaematology and Immunology of Transfusion Medicine, Institute of Haematology and Blood Transfusion, Warsaw, Poland.
Marcin CzerwinskiLaboratory of Glycobiology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Ludwik Hirszfeld Institute of Immunology and Experimental Therapy · PLInstytut Hematologii i Transfuzjologi · PLOpole University of Technology · PLNational Bank of Poland · PLUniversity of Opole · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Contrary to the mainstream blood group systems, P1PK continues to puzzle and generate controversies over its molecular background. The P1PK system comprises three glycosphingolipid antigens: Pk, P1 and NOR, all synthesised by a glycosyltransferase called Gb3/CD77 synthase. The Pk antigen is present in most individuals, whereas P1 frequency is lesser and varies regionally, thus underlying two common phenotypes: P1, if the P1 antigen is present, and P2, when P1 is absent. Null and NOR phenotypes are extremely rare. To date, several single nucleotide polymorphisms (SNPs) have been proposed to predict the P1/P2 status, but it has not been clear how important they are in general and in relation to each other, nor has it been clear how synthesis of NOR affects the P1 phenotype. Here, we quantitatively analysed the phenotypes and A4GALT transcription in relation to the previously proposed SNPs in a sample of 109 individuals, and addressed potential P1 antigen level confounders, most notably the red cell membrane cholesterol content. While all the SNPs were associated with the P1/P2 blood type and rs5751348 was the most reliable, we found large differences in P1 level within groups defined by their genotype and substantial intercohort overlaps, which shows that the P1PK blood group system still eludes full understanding.

Indexed as

Polymorphism, Single NucleotideAntibodiesBlood Group AntigensCholesterolFlow CytometryGalactosyltransferasesGenotypeGlobosidesGlycosphingolipidsHomozygoteHumansLipidsPhenotypeReal-Time Polymerase Chain ReactionAntibodiesBlood Group AntigensCholesterolgalactopyranosyl-1-4-paraglobosideGalactosyltransferasesGlobosidesGlycosphingolipidsLipidsUDP-galactose-lactosylceramide alpha 1-4-galactosyltransferase

Identifiers

PMID29709005
PMCPMC5927444
OpenAlexW2802279695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.